Shimadzu Opens New Solution Center in Maryland
Shimadzu's new Solution Center features additional research space.
Shimadzu Scientific Instruments
has opened its new Shimadzu Solution Center at its headquarters in Columbia, MD. The new 4100 ft
2
facility provides additional research space to more efficiently develop new software applications. The center also features video and conferencing equipment to facilitate customer interactions both within the center and in collaboration with manufacturing, software, and R&D groups.
Source:
Shimadzu Scientific Instruments
FDA Reopens Comment Period on HCP Immunogenicity Risk of Follow-on Recombinant Peptides
January 2nd 2025FDA is reopening the comment period for the Federal Register Notice, “Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant Peptide Products: Establishment of a Public Docket: Request for Information and Comments”, until March 3, 2025.
